Arjun Goyal Healthcare News

This is selected healthcare news for Arjun Goyal, which is filed under People. There are 6 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
4/5/2022 Affini-T Expands Board of Directors with Appointments of Michael Varney, Ph.D., and Daniel Faga
... powerhouse of industry leaders across biotechnology, venture capital, drug development and cell and gene therapy on Affini-T's board including Directors Jak Knowles, M.D. , Arjun Goyal, M.D., M.Phil ., and Lucio Iannone, Ph.D. , along with Observers Sebasti√°n Bernales, Ph.D. , Rakhshita Dhar and Sean Parker . Dr. Varney is a pioneer ...
Business Wire
3/23/2022 Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations
Co-founded at Fred Hutchinson Cancer Research Center with Phil Greenberg, M.D., Aude Chapuis, M.D., and Tom Schmitt, Ph.D., and Vida Ventures along with serial entrepreneurs Arjun Goyal, M.D., M.Phil., and Jak Knowles, M.D./ Foundational cell therapy platform builds upon seminal work from co-founders, leveraging a T Cell Receptor ...
thepharmadata.com
3/22/2022 Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations
... founded at Fred Hutchinson Cancer Research Center with Phil Greenberg, M.D., Aude Chapuis, M.D., and Tom Schmitt, Ph.D., and Vida Ventures along with serial entrepreneurs Arjun Goyal, M.D., M.Phil., and Jak Knowles, M.D. Foundational cell therapy platform builds upon seminal work from co-founders, leveraging a T Cell Receptor (TCR ...
mangaloremirror.com
3/22/2022 Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations
Co-founded at Fred Hutchinson Cancer Research Center with Phil Greenberg, M.D., Aude Chapuis, M.D., and Tom Schmitt, Ph.D., and Vida Ventures along with serial entrepreneurs Arjun Goyal, M.D., M.Phil., and Jak Knowles, M.D. F oundational cell therapy platform builds upon seminal work from co-founders, leveraging a T Cell ...
Yahoo News
7/18/2019 Vida Ventures Co-Leads $105 Million Series A Financing for Kronos Bio
... physicians, entrepreneurs and investors passionate about building and supporting breakthroughs in biomedicine. Vida founders include Arie Belldegrun, M.D., FACS, Fred Cohen, M.D., D.Phil, Leonard Potter, Arjun Goyal, M.D., and Stefan Vitorovic. Its inaugural fund currently has $355 million in assets under management from like-minded, long-term investors. “Our investment ...
Business Wire
7/18/2019 Vida Ventures Co-Leads $105 Million Series A Financing for Kronos Bio | Business & Finance | heraldchronicle.com
... physicians, entrepreneurs and investors passionate about building and supporting breakthroughs in biomedicine. Vida founders include Arie Belldegrun, M.D., FACS, Fred Cohen, M.D., D.Phil, Leonard Potter, Arjun Goyal, M.D., and Stefan Vitorovic. Its inaugural fund currently has $355 million in assets under management from like-minded, long-term investors. “Our investment ...
Business Wire